Work

Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.225

Authors: Ibrahim Halil Sahin, Subir Goyal, Yoanna S Pumpalova, Mohamad Bassam Sonbol, Satya Das, Sigurdis Haraldsdottir, Zhengjia Chen, Mehmet Akce, Olatunji B. Alese, Walid Labib Shaib, Daniel H. Ahn, Kristen Keon Ciombor, Jordan Berlin, Tanios S. Bekaii-Saab, Amber Draper, Gregory B. Lesinski, Bassel F. El-Rayes, Christina Wu

Institutions: Winship Cancer Institute, Stanford University, Mayo Clinic Hospital, Vanderbilt University Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Vanderbilt University, Emory University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3004867974

Cites:

Cited by: 4

Related to: 10